Abstract 4142394: HDL/ApoA1 inhibits macrophage ferroptosis via upregulating NRF2/SLC7A11/GSH pathway

Background: Ferroptosis is a novel type of programmed cell death characterized by excessive lipid peroxides and iron overload inside the cell. SLC7A11/GSH is one of the most important anti-ferroptotic pathways. Macrophage ferroptosis contributes to the progression of atherosclerosis. HDL exerts anti-atherosclerotic effects primarily by promoting cholesterol efflux. Whether HDL also inhibits macrophage ferroptosis is unknown. Research Questions: This research was aimed to explore the effects and mechanisms of HDL on macrophage ferroptosis. Methods: Macrophage ferroptosis was detected in plaques from patients with coronary artery disease. In vitro, macrophage was induced ferroptosis by multiple inducers and then the cells were treated with either vehicle or HDL or ApoA1. Ferroptosis was measured by detecting multiple ferroptosis markers (lipid peroxide, LDH release, ROS production, and cellular ferrous ion level). Results: Compared to controls, iron, lipid peroxide and macrophages were co-localized and significantly increased in coronary plaques, suggesting increased macrophage ferroptosis in atherosclerosis. In mouse macrophages, ferroptosis-inducers increased ferroptosis significantly, which was inhibited by HDL and ferroptosis inhibitors, but not neither by inhibitors of apoptosis, necroptosis, or autophagy. ApoA1, the main apolipoprotein on HDL, may account for HDL’s anti-ferroptotic effect. Mechanically, ApoA1 upregulated System Xc- (encoded by SLC7A11), an amino acid antiporter that exchanges intracellular glutamate and extracellular cysteine, thus elevating intracellular GSH and reducing ferroptosis. We further elucidated that ApoA1 activated NRF2, the transcription factor of SLC7A11, by promoting its nuclear translocation. Conclusion: Our results imply that HDL/ApoA1 inhibits macrophage ferroptosis via upregulating NRF2/SLC7A11/GSH pathway, enriching the regulation and mechanisms of HDL/ApoA1’s anti-atherosclerotic effects.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2024-11-12
DOI
https://doi.org/10.1161/circ.150.suppl_1.4142394
Citations
1
Primary Topic
Cancer-related molecular mechanisms research
Type
article
Field-Weighted Citation Impact
0.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4142394: HDL/ApoA1 inhibits macrophage ferroptosis via upregulating NRF2/SLC7A11/GSH pathway

Yongjie Deng, Yonghong Luo, Daoquan Peng, Yuting Yi
1 citations
Circulation
Cancer-related molecular mechanisms research
0.29
article

Abstract 4142394: HDL/ApoA1 inhibits macrophage ferroptosis via upregulating NRF2/SLC7A11/GSH pathway

Yongjie Deng, Yonghong Luo, Daoquan Peng, Yuting Yi
article en
1 citations

Abstract

Background: Ferroptosis is a novel type of programmed cell death characterized by excessive lipid peroxides and iron overload inside the cell. SLC7A11/GSH is one of the most important anti-ferroptotic pathways. Macrophage ferroptosis contributes to the progression of atherosclerosis. HDL exerts anti-atherosclerotic effects primarily by promoting cholesterol efflux. Whether HDL also inhibits macrophage ferroptosis is unknown. Research Questions: This research was aimed to explore the effects and mechanisms of HDL on macrophage ferroptosis. Methods: Macrophage ferroptosis was detected in plaques from patients with coronary artery disease. In vitro, macrophage was induced ferroptosis by multiple inducers and then the cells were treated with either vehicle or HDL or ApoA1. Ferroptosis was measured by detecting multiple ferroptosis markers (lipid peroxide, LDH release, ROS production, and cellular ferrous ion level). Results: Compared to controls, iron, lipid peroxide and macrophages were co-localized and significantly increased in coronary plaques, suggesting increased macrophage ferroptosis in atherosclerosis. In mouse macrophages, ferroptosis-inducers increased ferroptosis significantly, which was inhibited by HDL and ferroptosis inhibitors, but not neither by inhibitors of apoptosis, necroptosis, or autophagy. ApoA1, the main apolipoprotein on HDL, may account for HDL’s anti-ferroptotic effect. Mechanically, ApoA1 upregulated System Xc- (encoded by SLC7A11), an amino acid antiporter that exchanges intracellular glutamate and extracellular cysteine, thus elevating intracellular GSH and reducing ferroptosis. We further elucidated that ApoA1 activated NRF2, the transcription factor of SLC7A11, by promoting its nuclear translocation. Conclusion: Our results imply that HDL/ApoA1 inhibits macrophage ferroptosis via upregulating NRF2/SLC7A11/GSH pathway, enriching the regulation and mechanisms of HDL/ApoA1’s anti-atherosclerotic effects.

CirculationVol. 150(Suppl_1)
Central South University (CN), Second Xiangya Hospital of Central South University (CN)
Good health and well-being
Openalex Percentile: Top 38%
Cancer-related molecular mechanisms research
0.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.